Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 235,681,197 papers from all fields of science
Search
Sign In
Create Free Account
Debrisoquin
Known as:
2(1H)-Isoquinolinecarboximidamide, 3,4-dihydro-
, Debrisoquine
, Debrisochinum
Expand
An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
18 relations
Narrower (6)
3,4-dehydrodebrisoquine
4-hydroxydebrisoquin
8-hydroxydebrisoquin
Debrisoquine sulfate
Expand
Broader (5)
Adrenergic Agents
Antihypertensive Agents
Isoquinolines
Sympatholytics
Expand
In Blood
agonists
analogs & derivatives
antagonists & inhibitors
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
1986
1986
Debrisoquine oxidation in an Australian population.
G. Peart
,
J. Boutagy
,
G. Shenfield
British Journal of Clinical Pharmacology
1986
Corpus ID: 38502168
The standard laboratory method for determination of debrisoquine phenotype has been modified and shortened with no loss of…
Expand
Review
1986
Review
1986
Slow hydroxylation of tricyclic antidepressants--relationship to polymorphic drug oxidation.
F. Sjöqvist
,
L. Bertilsson
Progress in clinical and biological research
1986
Corpus ID: 24011394
There are marked interindividual differences in Css of tricyclic antidepressants. These are due mainly to corresponding…
Expand
Review
1986
Review
1986
Polymorphic oxidation of debrisoquine and sparteine.
M. Eichelbaum
Progress in clinical and biological research
1986
Corpus ID: 12722498
1983
1983
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.
M. Eichelbaum
,
L. Bertilsson
,
J. Säwe
British Journal of Clinical Pharmacology
1983
Corpus ID: 20342365
Thirty-five healthy subjects who had been classified as extensive or poor metabolizers of both sparteine and debrisoquine were…
Expand
1981
1981
Influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation.
M. Danhof
,
J. Idle
,
M. Teunissen
,
T. Sloan
,
D. Breimer
,
R. Smith
Pharmacology
1981
Corpus ID: 46771871
The influence of the genetically controlled deficiency in debrisoquine hydroxylation on antipyrine metabolite formation was…
Expand
1980
1980
Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension.
P. Weidmann
,
M. Grimm
,
+4 authors
C. Beretta‐Piccoli
Clinical and experimental hypertension
1980
Corpus ID: 22394378
The role of the adrenergic effector-response axis in the pathogenesis of essential hypertension and in the hypotensive mechanism…
Expand
1978
1978
The disposition of debrisoquine in hypertensive patients.
J. Silas
,
M. Lennard
,
G. Tucker
,
A. Smith
,
S. Malcolm
,
T. Marten
British Journal of Clinical Pharmacology
1978
Corpus ID: 10915793
1 The urinary recovery and plasma concentration of debrisoquine (D) and its metabolite 4-hydroxydebrisoquine (HD) has been…
Expand
1976
1976
Metabolism of debrisoquine sulphate in rat, dog and man.
J. Allen
,
A. Brown
,
T. Marten
Xenobiotica; the fate of foreign compounds in…
1976
Corpus ID: 21427751
1. The metabolism of debrisoquine sulphate in the dog has been studied and is similar to that in rat and man. 2. Two acidic…
Expand
1975
1975
Metabolism of debrisoquine sulfate. Identification of some urinary metabolites in rat and man.
J. Allen
,
P. B. East
,
R. Francis
,
J. Haigh
Drug Metabolism And Disposition
1975
Corpus ID: 38307736
A high proportion of an oral dose of 14C-debrisoquine sulfate is excreted in the urine by rat and man. The urinary radioactivity…
Expand
1966
1966
Studies on debrisoquine sulphate.
G. E. Chittenden
,
Heide E C
,
+24 authors
R. Turnert
British medical journal
1966
Corpus ID: 6377944
caused by bacterial strains whose patterns of resistance exclude the usual primary agents-sulphanilamide, nitrofurantoin, and…
Expand